TD Cowen analyst Robert Moskow maintained a Buy rating on Procter & Gamble (PG – Research Report) today and set a price target of $189.00. Robert Moskow’s rating is based on the strong performance ...
Market participants were in full risk-on mode Wednesday as an AI-fueled rally in big tech stocks and a batch of upbeat ...
In the latest trading session, Procter & Gamble (PG) closed at $168.11, marking a +0.03% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.73%.
Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of ...
The organic sales gain included a 3% increase for the Health Care segment. Oral Care organic sales increased low single ...
Consumers say they were misled by environmental claims Lawsuit claims company harms important Canadian forest Procter & Gamble has pledged more disclosures Jan 17 (Reuters) - A new lawsuit accuses ...
Procter & Gamble Hygiene & Healthcare Ltd. key Products/Revenue Segments include Hygiene Products, Creams & Ointments, Cough Drops, Tablets for the year ending 30-Jun-2024.For the quarter ended 30 ...
Project Stargate will see companies like Oracle, SoftBank, MGX, and OpenAI commit an initial $100 billion to build data ...